L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction

Détails

ID Serval
serval:BIB_8A7FC753084F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction
Périodique
Neurology
Auteur⸱e⸱s
Russmann  H., Ghika  J., Combrement  P., Villemure  J. G., Bogousslavsky  J., Burkhard  P. R., Vingerhoets  F. J.
ISSN
1526-632X (Electronic)
Statut éditorial
Publié
Date de publication
07/2004
Volume
63
Numéro
1
Pages
153-5
Notes
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Jul 13
Résumé
The authors studied the long-term evolution of levodopa-induced dyskinesia (LID) after levodopa challenge in two groups of six STN-deep brain stimulation-treated Parkinson disease (PD) patients, one requiring medication after surgery and the other not. A dramatic (96%) reduction of LID severity was obtained in the six postoperatively untreated patients compared to a moderate improvement (47%) in the treated group (p < 0.03). These data support dopaminergic stimulation and striatal desensitization as major determinants of LID in PD.
Mots-clé
Aged Aged, 80 and over Antiparkinson Agents/administration & dosage/*adverse effects/diagnostic use/therapeutic use Combined Modality Therapy Corpus Striatum/physiopathology *Deep Brain Stimulation Dose-Response Relationship, Drug Dyskinesia, Drug-Induced/*etiology/physiopathology Female Humans Levodopa/administration & dosage/*adverse effects/diagnostic use/therapeutic use Male Middle Aged Parkinson Disease/drug therapy/*therapy Receptors, Dopamine/drug effects Severity of Illness Index
Pubmed
Web of science
Création de la notice
25/01/2008 12:48
Dernière modification de la notice
20/08/2019 14:49
Données d'usage